![Mark Lanasa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lanasa
Corporate Officer/Principal at
BEIGENE LTD
Profile
Mark Lanasa currently works at BeOne Medicines Ltd., as Chief Medical Officer-Solid Tumors & SVP from 2022.
Mr. Lanasa also formerly worked at AstraZeneca PLC, as Vice President & Head-Enhertu Global Clinical from 2019 to 2022.
Mr. Lanasa received his undergraduate degree from The Pennsylvania State University and graduate degree and doctorate degree from the University of Pittsburgh School of Medicine.
Mark Lanasa active positions
| Companies | Position | Start |
|---|---|---|
| BEIGENE LTD | Corporate Officer/Principal | 09/02/2022 |
Former positions of Mark Lanasa
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2022 |
Training of Mark Lanasa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Mark Lanasa
